Aveanna Healthcare (AVAH) Stock Price, News & Analysis

Company Overview

Aveanna Healthcare is a leading provider of in-home health care services across the United States, specializing in pediatric and adult home health, hospice support and complementary therapy services. Through a nationwide network of caregivers and clinical professionals, the company delivers customized care plans designed to meet the unique medical needs of each patient. Aveanna’s service model emphasizes continuity of care, ensuring that skilled nurses, therapists and aides collaborate closely with physicians and families to improve patient outcomes and quality of life.

The company’s core offerings include nursing services such as skilled pediatric nursing, infusion therapy and tracheostomy care, as well as rehabilitative therapies encompassing physical, occupational and speech therapy. Aveanna also provides personal care services for activities of daily living, respite care for family caregivers and medical social support. By integrating telehealth solutions, remote monitoring and care coordination, the company enhances access to care and strengthens clinical oversight, particularly for patients managing chronic or complex conditions at home.

Formed through the consolidation of several regional home health providers, Aveanna Healthcare has pursued an active acquisition strategy to expand its geographic footprint and augment its service capabilities. Since going public, the company has invested in technology platforms that streamline claims processing, caregiver scheduling and electronic health record integration. These initiatives help ensure regulatory compliance, improve operational efficiency and facilitate more timely reimbursement for payors and providers alike.

Headquartered in King of Prussia, Pennsylvania, Aveanna serves patients in urban, suburban and rural markets across multiple states. The company’s leadership team brings decades of combined experience in home health care, pediatric nursing and health care operations. This depth of expertise enables Aveanna to navigate a complex regulatory environment, forge partnerships with payors and referral sources, and invest in workforce development programs that attract and retain qualified clinicians.

Key Stats

• Today's Range: $4.39 to $4.65
• 50-Day Range: $4.46 to $6.00
• 52-Week Range: $2.47 to $6.19
• Volume: 480,689 shs
• Average Volume: 341,934 shs
• Market Capitalization: $902.29 million
• P/E Ratio: 231.25
• Dividend Yield: N/A
• Price Target: $5.20
• Consensus Rating: Hold

Aveanna Healthcare Stock Analysis - MarketRank™

Aveanna Healthcare scored higher than 23% of companies evaluated by MarketBeat, and ranked 828th out of 929 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.0 / 5
• Analyst Rating: Hold

Consensus Rating

Aveanna Healthcare has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 3 hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Aveanna Healthcare has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Aveanna Healthcare is 231.25, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.61.

Price to Earnings Ratio vs. Sector

The P/E ratio of Aveanna Healthcare is 231.25, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.43.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

3.97% of the float of Aveanna Healthcare has been sold short.

Short Interest Ratio / Days to Cover

Aveanna Healthcare has a short interest ratio ("days to cover") of 4.7.

Change versus previous month

Short interest in Aveanna Healthcare has recently increased by 22.75%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Aveanna Healthcare does not currently pay a dividend.

Dividend Growth

Aveanna Healthcare does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

3.97% of the float of Aveanna Healthcare has been sold short.

Short Interest Ratio / Days to Cover

Aveanna Healthcare has a short interest ratio ("days to cover") of 4.7.

Change versus previous month

Short interest in Aveanna Healthcare has recently increased by 22.75%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.4 / 5
• News Sentiment: 0.26

News Sentiment

Aveanna Healthcare has a news sentiment score of 0.26. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 8 news articles for Aveanna Healthcare this week, compared to 3 articles on an average week.

Search Interest

1 people have searched for AVAH on MarketBeat in the last 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Aveanna Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $37,838,057.00 in company stock.

Percentage Held by Insiders

Only 7.80% of the stock of Aveanna Healthcare is held by insiders.

Percentage Held by Institutions

87.96% of the stock of Aveanna Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

AVAH Stock Analysis - Frequently Asked Questions

How have AVAH shares performed this year?

Aveanna Healthcare's stock was trading at $4.57 on January 1st, 2025. Since then, AVAH stock has increased by 1.2% and is now trading at $4.6250.

How were Aveanna Healthcare's earnings last quarter?

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) announced its quarterly earnings results on Thursday, November, 7th. The company reported $0.02 earnings per share for the quarter, beating analysts' consensus estimates of ($0.01) by $0.03. The firm earned $509.02 million during the quarter, compared to analyst estimates of $495.80 million. Aveanna Healthcare had a negative trailing twelve-month return on equity of 15.16% and a net margin of 0.26%.
Read the conference call transcript.

When did Aveanna Healthcare IPO?

Aveanna Healthcare (AVAH) raised $478 million in an initial public offering (IPO) on Thursday, April 29th 2021. The company issued 38,200,000 shares at $12.00-$13.00 per share. Barclays, J.P. Morgan, BMO Capital Markets and Credit Suisse acted as the underwriters for the IPO and BofA Securities, Deutsche Bank Securities, Jefferies, RBC Capital Markets, Truist Securities, Raymond James, Stephens Inc., Drexel Hamilton and Siebert Williams Shank were co-managers.

How do I buy shares of Aveanna Healthcare?

Shares of AVAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Aveanna Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Aveanna Healthcare investors own include American Water Works (AWK), Waste Connections (WCN), The RMR Group (RMR), AU Optronics (AUOTY), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and Voyager Therapeutics (VYGR).

Company Calendar

• Last Earnings: 11/07/2024
• Today: 7/05/2025
• Next Earnings (Estimated): 8/06/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - OUTP/HM CRE
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:AVAH
• CIK: 1832332
• Web: www.aveanna.com
• Phone: 770-441-1580
• Fax: N/A
• Employees: 33,500
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $5.20
• High Stock Price Target: $5.50
• Low Stock Price Target: $5.00
• Potential Upside/Downside: +12.4%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 5 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.02
• Trailing P/E Ratio: 231.25
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$10.93 million
• Net Margins: 0.26%
• Pretax Margin: 0.66%
• Return on Equity: -15.16%
• Return on Assets: 1.14%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.05
• Quick Ratio: 1.05

Sales & Book Value

• Annual Sales: $2.02 billion
• Price / Sales: 0.45
• Cash Flow: $0.16 per share
• Price / Cash Flow: 28.36
• Book Value: ($0.64) per share
• Price / Book: -7.23

Miscellaneous

• Outstanding Shares: 195,090,000
• Free Float: 179,877,000
• Market Cap: $902.29 million
• Optionable: Optionable
• Beta: 1.98